Abstract:Modulation of tumor-associated macrophages (TAMs) holds promise for cancer treatment, mainly relying on M1 signaling activation and pro-inflammatory promotion. Nevertheless, the antitumor activity is often limited by the anti-inflammatory factors in the tumor microenvironment. Moreover, the metabolic function of TAMs is also critical to tumor progression. However, there are a few strategies that can simultaneously regulate both inflammatory and metabolic functions to achieve safe and potent antitumor activation of TAMs. Herein, we demonstrate that an iron-based metal organic framework nanoparticle and a ferroptosis-inducing agent synergistically induce mitochondrial alternation in TAMs, resulting in a radical metabolic switch from mitochondrial oxidative phosphorylation to glycolysis, which is resistant to anti-inflammatory stimuli challenge. The ferroptosis stress strengthened by the nanoformulation also drives multiple pro-inflammatory signaling pathways, enabling macrophage activation with potent tumoricidal activities. The ferroptosis-strengthened macrophage regulation strategy present in this study paves the way for TAM-centered antitumoral treatment to overcome the limitations of conventional methods.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.nanolett.1c01401.Detailed methods on the synthesis and characterization of the nanoparticles, cell culture procedures, cell viability tests, determination of the expression of GPX4 in the macrophages, phenotypic and metabolic investigation methods of programmed macrophages, characterization of mitochondrial alternation, and in vivo assays and related figures (PDF)This article has not yet been cited by other publications.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the tumor - promoting role of tumor - associated macrophages (TAMs) in the tumor microenvironment. Specifically, the paper focuses on how to enhance the tumor - killing activity of TAMs by regulating their transformation from the tumor - promoting M2 phenotype to the anti - tumor M1 phenotype. Although traditional methods such as the use of lipopolysaccharide (LPS) and interferon - γ (IFN - γ) can induce the M1 phenotype, their effects are limited and they have side effects. Therefore, this paper proposes a new strategy, that is, using iron - based metal - organic framework nanoparticles (Fe - MOF) and ferroptosis inducers (such as RSL3) to synergistically regulate the metabolism and inflammatory functions of TAMs by enhancing ferroptosis, thereby achieving more effective anti - tumor effects. ### Main problems 1. **Regulation of the metabolic and inflammatory functions of TAMs**: - **Metabolic regulation**: Although traditional M1 stimulants such as LPS and IFN - γ can induce the M1 phenotype, they rely on mitochondrial oxidative phosphorylation (OXPHO), which may limit their anti - tumor effects. The method proposed in this paper induces ferroptosis, causing the metabolism of TAMs to shift from OXPHO to glycolysis, thereby enhancing their anti - tumor ability. - **Inflammatory function regulation**: The enhancement of ferroptosis not only changes the metabolic pathway but also activates multiple pro - inflammatory signaling pathways, further enhancing the activation of the M1 phenotype. 2. **Overcoming the limitations of traditional methods**: - **Challenge of anti - inflammatory factors**: There are a large number of anti - inflammatory factors in the tumor microenvironment, which will inhibit the activation of the M1 phenotype. The method proposed in this paper, through the enhancement of ferroptosis, makes the regulation of the metabolic and inflammatory functions of TAMs more stable and able to resist the challenge of anti - inflammatory factors. - **Side effects**: Traditional methods such as LPS and IFN - γ have obvious side effects, which limit their clinical applications. The Fe - MOF and RSL3 combination proposed in this paper has lower toxicity and higher safety. ### Solutions 1. **Iron - based metal - organic framework nanoparticles (Fe - MOF)**: - Fe - MOF nanoparticles can release iron ions. These iron ions generate reactive oxygen species (ROS) through the Fenton reaction, leading to lipid peroxidation, further destroying the mitochondrial structure and triggering ferroptosis. - Fe - MOF nanoparticles can also load RSL3 to further enhance the ferroptosis effect. 2. **Ferroptosis inducer RSL3**: - RSL3 is a ferroptosis activator that can enhance iron - dependent lipid peroxidation and further promote ferroptosis. - RSL3 and Fe - MOF nanoparticles can work synergistically to more effectively inhibit OXPHO and promote the shift of TAMs' metabolism from OXPHO to glycolysis. 3. **Experimental verification**: - Through in vitro experiments, it has been proved that the MIL88B/RSL3 combination can significantly inhibit OXPHO, enhance glycolysis, and activate multiple pro - inflammatory signaling pathways, thereby inducing strong activation of the M1 phenotype. - Through in vivo experiments, it has been verified that the MIL88B/RSL3 combination can significantly increase the proportion of TAMs with the M1 phenotype in a mouse breast cancer model, enhance their phagocytic and killing abilities against tumor cells, and inhibit tumor growth and metastasis. ### Conclusion The ferroptosis - enhanced TAMs regulation strategy proposed in this paper achieves more powerful anti - tumor effects than traditional methods by simultaneously regulating metabolic and inflammatory functions. This strategy not only provides a stronger pro - inflammatory output but also can resist the challenge of anti - inflammatory factors and has potential clinical application value. Future research can further explore the combined application of this strategy with other chemotherapy or immunotherapy drugs to promote the development of cancer treatment.

Ferroptosis-Strengthened Metabolic and Inflammatory Regulation of Tumor-Associated Macrophages Provokes Potent Tumoricidal Activities

Biomimetic inducer enabled dual ferroptosis of tumor and M2-type macrophages for enhanced tumor immunotherapy

Targeting the Macrophage-Ferroptosis Crosstalk: A Novel Insight into Tumor Immunotherapy

Modulating Repolarization of Tumor-Associated Macrophages with Targeted Therapeutic Nanoparticles as a Potential Strategy for Cancer Therapy

Anti-tumor Macrophages Activated by Ferumoxytol Combined or Surface-Functionalized with the TLR3 Agonist Poly (I : C) Promote Melanoma Regression.

Targeted xCT‐mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti‐PD‐1/L1 Response

Remodeling Macrophages by an Iron Nanotrap for Tumor Growth Suppression

Nanomaterials in modulating tumor-associated macrophages and enhancing immunotherapy

Ferroptosis Nanomedicine: Clinical Challenges and Opportunities for Modulating Tumor Metabolic and Immunological Landscape

Iron chelated melanin-like nanoparticles for tumor-associated macrophage repolarization and cancer therapy

Polarization of tumor-associated macrophage phenotype via porous hollow iron nanoparticles for tumor immunotherapy in vivo.

Nanomaterials targeting tumor associated macrophages for cancer immunotherapy

Tetrahydrobiopterin inhibitor-based antioxidant metabolic strategy for enhanced cancer ferroptosis-immunotherapy

Biomaterial-Mediated Metabolic Regulation of Ferroptosis for Cancer Immunotherapy.

Metal ions/nucleotide coordinated nanoparticles comprehensively suppress tumor by synergizing ferroptosis with energy metabolism interference

A Dihydroartemisinin‐Loaded Nanoreactor Motivates Anti‐Cancer Immunotherapy by Synergy‐Induced Ferroptosis to Activate Cgas/STING for Reprogramming of Macrophage

Biomimetic Iron-Based Nanoparticles Remodel Immunosuppressive Tumor Microenvironment for Metabolic Immunotherapy

A Multimodal Therapeutic Nano-Prodrug As an Oxidative Stress Amplifier Induces Apoptosis and Ferroptosis for Cancer Therapy

Polymeric Nanoparticles Promote Macrophage Reversal from M2 to M1 Phenotypes in the Tumor Microenvironment.

Metabolic Control by Heat Stress Determining Cell Fate to Ferroptosis for Effective Cancer Therapy

Phospholipid peroxidation in macrophage confers tumor resistance by suppressing phagocytic capability towards ferroptotic cells